Cargando…
House dust mite-specific immunotherapy and tropomyosin sensitizations: harm or benefit for patients?
Autores principales: | Pevec, B, Pevec, M Radulovic, Markovic, A Stipic, Batista, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723639/ http://dx.doi.org/10.1186/2045-7022-3-S3-P44 |
Ejemplares similares
-
Shellfish and House Dust Mite Allergies: Is the Link Tropomyosin?
por: Wong, Lydia, et al.
Publicado: (2016) -
Tropomyosin in mugwort cross-reacts to house dust mite, eliciting non-Th2 response in allergic rhinitis patients sensitized to house dust mite
por: Duan, Su, et al.
Publicado: (2021) -
Optimization of the basophil activation test in the diagnosis and qualification for treatment by means of allergen-specific immunotherapy in children with respiratory allergy to house dust mites
por: Spiewak, Radoslaw, et al.
Publicado: (2015) -
Influenza exacerbations in an acute and chronic house dust mite ‘asthma’ model
por: Bal, Suzanne M, et al.
Publicado: (2013) -
Immunotherapy of house dust mite allergy
por: Yang, Lin, et al.
Publicado: (2017)